|
2024
|
Invention
|
Vesicular stomatitis virus lassa virus vaccine. Lassa fever is a zoonotic viral hemorrhagic disea... |
|
|
Invention
|
Tuberculosis antigen cassettes.
The present disclosure provides fusion proteins comprising Mycob... |
|
|
Invention
|
Monoclonal antibodies directed against trimeric forms of the hiv-1 envelope glycoprotein with bro... |
|
|
Invention
|
Immunogenic trimers.
The invention relates to PGT121-germline-targeting designs, trimer stabiliz... |
|
|
Invention
|
Influenza estem immunogens. The present invention relates to influenza immunogens and a vaccine p... |
|
2023
|
Invention
|
Vaccine compositions for preventing coronavirus disease.
The present disclosure provides Severe ... |
|
|
Invention
|
Recombinant cytomegalovirus vectors as vaccines for tuberculosis.
The present disclosure provide... |
|
|
Invention
|
Tuberculosis compositions and methods of using the same.
The present disclosure provides fusion ... |
|
|
Invention
|
Vesicular stomatitis virus marburg virus vaccine. The present invention relates to a vesicular st... |
|
|
Invention
|
Immunogenic proteins and nucleic acids encoding the same. The invention relates to proteins and n... |
|
|
Invention
|
Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus t... |
|
|
Invention
|
Vesicular stomatitis virus and virus rescue system. The present relation relates to recombinant v... |
|
|
Invention
|
Tuberculosis compositions and methods of treating or preventing tuberculosis.
The present disclo... |
|
|
Invention
|
Tuberculosis antigen cassettes. Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules... |
|
2022
|
Invention
|
Modified immunogenic proteins.
The invention relates to germline-targeting designs, stabilizatio... |
|
|
Invention
|
Potently neutralizing novel human monoclonal antibodies against sars-cov-2 (covid-19). The presen... |
|
|
Invention
|
Stable, spray dried, immunogenic, viral compositions.
Viruses, and particularly genetically engi... |
|
|
Invention
|
Coronavirus antibodies and uses thereof. This application provides compositions and methods for t... |
|
2021
|
Invention
|
Recombinant cytomegalovirus vectors as vaccines for tuberculosis. Disclosed herein are cytomegalo... |
|
|
Invention
|
Recombinant hiv env polypeptides and their use. The present disclosure relates to recombinant HIV... |
|
|
Invention
|
Covid-19 antibodies and uses thereof.
The present application is directed to recombinant monoclo... |
|
|
Invention
|
Covid-19 antibodies and uses thereof. The present application is directed to recombinant monoclon... |
|
|
Invention
|
Tuberculosis compositions and methods of using the same. Mycobacterium tuberculosis (Mtb) antigen... |
|
|
Invention
|
Replication-competent attenuated chimeric vsv vectors encoding immunogenic sars-cov-2 spike prote... |
|
|
Invention
|
Vaccine compositions for preventing coronavirus disease. The present disclosure provides Severe A... |
|
2020
|
Invention
|
Recombinant viral vectors. The present relation relates to recombinant vesicular stomatitis virus... |
|
|
Invention
|
Stable, spray dried, immunogenic, viral compositions. Viruses, and particularly genetically engin... |
|
2019
|
Invention
|
Tuberculosis compositions and methods of treating or preventing tuberculosis. Mycobacterium tuber... |
|
2018
|
Invention
|
Tuberculosis antigen cassettes. Mycobacterium tuberculosisMycobacterium tuberculosis (Mtb) antige... |
|
2017
|
Invention
|
Recombinant cytomegalovirus vectors as vaccines for tuberculosis. Mycobacterium tuberculosis (Mtb... |
|
|
Invention
|
Recombinant cytomegalovirus vectors as vaccines for tuberculosis. The present disclosure provides... |
|
|
Invention
|
Tuberculosis compositions and methods of treating or preventing tuberculosis. The present disclos... |
|
|
Invention
|
Stable, spray dryed, immunogenic, viral compositions.
Viruses, and particularly genetically engi... |
|
2013
|
Invention
|
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing s... |
|
2010
|
Invention
|
Stable, spray dryed, immunogenic, viral compositions. Viruses, and particularly genetically engin... |
|
2009
|
Invention
|
Recombinant bcg strains with enhanced ability to escape the endosome. Mycobacterium strains. |
|
|
Invention
|
Recombinant bcg tuberculosis vaccine designed to elicit immune responses to mycobacterium tubercu... |
|
|
Invention
|
Malaria vaccine compositions and constituents which elicit cell mediated immunity. Plasmodium fal... |
|
2001
|
P/S
|
[ Printed instructional, educational and teaching materials, namely, pamphlets, brochures, books,... |
|
|
P/S
|
Printed instructional, educational and teaching materials, namely pamphlets, brochures, books, ne... |
|
|
P/S
|
Printed instructional, educational and teaching materials, namely, pamphlets, brochures, books, n... |
